Ireland - English - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - ferrous sulfate; sodium ascorbate - prolonged-release tablet - 325 mg/500 milligram(s) - iron bivalent, oral preparations; ferrous sulfate

Canada - English - Health Canada

duchesnay inc - folic acid; vitamin e (dl-alpha tocopheryl acetate); ascorbic acid (ascorbic acid); vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); d-pantothenic acid (calcium d-pantothenate); magnesium (magnesium oxide); iodine (potassium iodide); iron (ferrous fumarate); copper (cupric oxide); zinc (zinc oxide); vitamin b12 (cyanocobalamin); vitamin d3 (cholecalciferol); calcium (calcium carbonate); beta-carotene - tablet - 5mg; 13.8mg; 120mg; 3mg; 3.4mg; 20mg; 10mg; 5mg; 50mg; 0.15mg; 35mg; 2mg; 15mg; 12mcg; 250unit; 300mg; 1.6mg - folic acid 5mg; vitamin e (dl-alpha tocopheryl acetate) 13.8mg; ascorbic acid (ascorbic acid) 120mg; vitamin b1 (thiamine mononitrate) 3mg; vitamin b2 (riboflavin) 3.4mg; nicotinamide 20mg; vitamin b6 (pyridoxine hydrochloride) 10mg; d-pantothenic acid (calcium d-pantothenate) 5mg; magnesium (magnesium oxide) 50mg; iodine (potassium iodide) 0.15mg; iron (ferrous fumarate) 35mg; copper (cupric oxide) 2mg; zinc (zinc oxide) 15mg; vitamin b12 (cyanocobalamin) 12mcg; vitamin d3 (cholecalciferol) 250unit; calcium (calcium carbonate) 300mg; beta-carotene 1.6mg - vitamins & minerals

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - folic acid, quantity: 0.35 mg; ferrous fumarate, quantity: 310 mg - tablet, film coated - excipient ingredients: purified talc; magnesium stearate; hypromellose; sodium lauryl sulfate; iron oxide red; sodium starch glycollate; povidone; glycerol; microcrystalline cellulose; titanium dioxide; macrogol 6000; macrogol 400 - source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemia, including in pregnancy.

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - ferrous gluconate - tablet - ferrous gluconate 300 mg - antianemic preparations

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - multivitamins , minerals (vet.) - chewable tablet - formulation: each chewable tablet contains: retinyl acetate (vitamin a)5,000 iu colecalciferol (vitamin d.) 400 iu riboflavin (vitamin bs) 3 mg dl-alpha tocophreyl acetate (vitamin e) 25 iu thiamine hydrochloride (vitamin b1)1.5 mg folic acid (vitamin b9) 1 mg ascorbic acid (vitamin c) 50 mg cyanocobalamin (vitamin b12)2 μg niacinamide (vitamin b1) 15 mg ferrous sulfate 30 mg pyridoxine hydrochloride (vitamin b6) 5 mg calcium pantothenate (vitamin b12) 5 mg magnesium sulfate heptahydrate3 mg potassium iodide 150 μg

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - ferrous sulfate - dried,folic acid -

Philippines - English - FDA (Food And Drug Administration)

onesource pharma solutions, inc. - iron (as ferrous sulphate heptahydrate) , folic acid - tablet - 60mg/250mcg

Philippines - English - FDA (Food And Drug Administration)

unilab, inc. - iron , pyridoxine (vitamin b6) , cyanocobalamin (vitamin b12) folic acid - tablet - each tablet contains: iron, elemental (as ferrous sulfate dried, 187 mg) - 60 mg folic acid - 600 mcg pyridoxine hcl (vit b6) - 20 mg cyanocobalamin (vit b12) - 25 mcg

United States - English - NLM (National Library of Medicine)

puretek corporation - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous c - thiamine 3 mg - prenatal + dha™ is indicated to provide vitamin/mineral and dha omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. prenatal + dha™ may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

centurion labs, llc - omega-3 fatty acids (unii: 71m78end5s) (omega-3 fatty acids - unii:71m78end5s), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), .alpha.-tocopherol, d- (unii: n9pr3490h9) (.alpha.-tocopherol, d- - unii:n9pr3490h9), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a) - omega-3 fatty acids 200 mg - indications and usage: c-nate dha is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. contraindications: c-nate dha should not be used by patients with known history of hypersensitivity to any of the listed ingredients. pediatric use: safety and effectiveness in pediactric patients has not been established. geriactric use: no clinical studies have been performed in patients over 65 to determine whether older persons respond differently from younger persons. physicians should consider that elderly person may have decreased hepatic, renal, or cardiac function.